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ABSTRACT: When nanoparticles (NPs) are exposed to
biological media, proteins are adsorbed, forming a so-called
protein corona (PC). This cloud of protein aggregates hampers
the targeting and transport capabilities of the NPs, thereby
compromising their biomedical applications. Therefore, there is
a high interest in the development of technologies that allow
control over PC formation, as this would provide a handle to
manipulate NPs in biological fluids. We present a strategy that
enables the reversible disruption of the PC using external
stimuli, thereby allowing a precise regulation of NP cellular
uptake. The approach, demonstrated for gold nanoparticles
(AuNPs), is based on a biorthogonal, supramolecular host−
guest interactions between an anionic dye bound to the AuNP surface and a positively charged macromolecular cage. This
supramolecular complex effectively behaves as a zwitterionic NP ligand, which is able not only to prevent PC formation but
also to disrupt a previously formed hard corona. With this supramolecular stimulus, the cellular internalization of AuNPs can
be enhanced by up to 30-fold in some cases, and even NP cellular uptake in phagocytic cells can be regulated. Additionally, we
demonstrate that the conditional cell uptake of purposely designed gold nanorods can be used to selectively enhance
photothermal cell death.
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Nanoparticles (NPs) have gained great momentum inbiomedicine, owing to their applications in diagnosis,drug delivery, and multimodal imaging, among other
areas.1−4 Gold NPs have been of particular interest because of
their low intrinsic cytotoxicity, easy customization of
morphology and surface functionalization, and the possibility
of using their plasmonic properties to unleash biological
responses.5−7 In the area of cancer and related cellular diseases,
a number of applications for detecting and/or killing cancer
cells have been proposed.8,9 However, biomedical application
of these NP-based strategies can be hampered by insufficient
cellular uptake and reduced in vivo transport.10 Additional
limitations are related to scavenging by the mononuclear
phagocyte system, which results in NPs being trapped in the
liver and spleen,11 as well as to the lack of spatial and temporal
control over their biological activity.
Many such limitations are related to the well-established
tendency of NPs to adsorb biomolecules, physiological
proteins, in particular, forming the so-called “protein corona”
(PC). When NPs are in a biological milieu such as the
bloodstream, plasma proteins readily bind to their surfaces and
form a PC that affects their physicochemical properties and
compromises their transport, targeting, and cell uptake
capabilities.12,13 Indeed, PC formation usually hampers direct
contact of NPs with cell membranes, in turn inhibiting their
internalization.14,15
Therefore, a major challenge in this field of biological
chemistry involves the development of methods that provide
control over PC formation on the NPs surface. In this context,
research efforts have been mainly focused on two strategies to
deal with the PC issue. The first one relies on the development
of methods to control PC composition and improve NP
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biocompatibility,16 while the second strategy intends to
prevent PC formation. Regarding the latter, the most common
approach to reduce PC formation on NPs is based on
precoating the NPs surface with hydrophilic polymers such as
poly(ethylene glycol) (PEG).17,18 However, PEG coating can
block protein adsorption only partially, and it has been
reported that some plasma proteins (e.g., apolipoprotein E,
IgG, etc.) can adsorb over PEG-coated surfaces.19 An
alternative to PEG coating toward avoiding PC formation
comprises the use of zwitterionic surface ligands. Strong
electrostatic interactions between water molecules and
zwitterionic ligands generate highly stable NPs, while
Figure 1. Supramolecular control over PC formation. (A) Chemical structures of the guest molecule pyr and the host cage A (the chemical
structure of only one edge of the tetrahedral cage A is shown for clarity). (B) Schematic illustration of the reversible control over PC
formation on AuNPs, using a supramolecular host−guest complex between negatively charged pyr and positively charged cage A.
Figure 2. NS2 synthesis and evaluation of its interaction with cage A. (A) Synthesis scheme and Zp characterization of NS1 and NS2. (B) Zp
distributions for NS2 after addition of cage A. (black) 2 × 1011 particles/mL suspension of NS2 in Milli-Q water (−37 ± 2 mV). (red) After
addition of 0.3 μM of A (+8 ± 2 mV). (green) After addition of 3 μM of A (+31 ± 2 mV). (purple) After addition of 5 μM of A (+32 ± 3
mV). (C) UV−Vis spectra of NS2 (1.5 × 1011 particles/mL) before and after addition of cage A. (black) NS2 in Milli-Q water. (red) After
addition of 5 μM of A. (green) After addition of 10 μM of A. (D) Representative TEM corresponding to the sample with the red spectrum in
(C).
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minimizing nonspecific interactions with biomolecules.20
Zwitterionic ligands have been shown to inhibit PC formation
completely in some specific cases,21 thereby leading to
extended NP circulation lifetimes.22
Recently, an oligocationic covalent cage A, which enables
the conversion of the negatively charged dye pyranine (pyr)
into a positively charged host−guest complex, has been
described (Figure 1A).23 This macromolecular cage has high
selectivity and nanomolar affinity (Kd ≈ 1.2 nM) for pyr, and
the resulting interaction has been used in biological
applications.24,25 Additionally, its small size and straightfor-
ward functionalization render cage A a suitable candidate to be
formulated into different dosage forms for use as a chemical
stimulus.
We recently reported that small (2 nm) AuNPs carrying
negatively charged pyranine molecules on their surface do not
internalize into cells, whereas surface charge reversal by
addition of cage A promotes their cellular uptake.26 This
switch is effective with small NPs, which do not tend to form a
PC, but a priori it might not work in the case of larger NPs.
However, we envisioned that the host−guest interaction might
be used as a handle to control the zwitterionic character of
large NPs and, thereby, influence PC formation and cellular
uptake. Herein we demonstrate that the PC formed on
pyranine-functionalized 15 nm gold nanoparticles can be
efficiently disrupted by judicious addition of the macro-
molecular cage A (Figure 1B). Importantly, the initial state
(adsorbed proteins) can be recovered by adding a molecular
guest that outcompetes for the host macromolecular cage,
thereby providing reversible control over PC formation. This
approach can be additionally used for the programmed cellular
uptake of gold nanorods, which allows establishing a cell-
selective photothermal therapy.
RESULTS AND DISCUSSION
Citrate-stabilized Au nanospheres (AuNSs, 15 nm diameter)
were initially coated with thiolated amino-polyethylene glycol
(HS-PEG-NH2), resulting in AuNSs featuring exposed amino
groups (NS1, Figure 2A). Subsequently, anionic pyranines
bearing a carboxylic acid handle were covalently attached, to
yield the expected pyr-derivatized nanoparticles NS2.
Successful functionalization of NS1 with pyr was confirmed
by zeta potential (Zp) measurements, since the Zp value
shifted from +29 mV for NS1 to −37 mV for NS2 (Figure 2A).
The colloidal stability of AuNPs during synthesis was verified
by transmission electron microscopy (TEM) and UV−vis
spectroscopy (Supporting Information Figures S1 and S2).
Fluorescence spectroscopy after cyanide digestion of NS2
showed that the average number of pyr molecules per NP was
ca. 400.
Prior to studying PC formation, we evaluated the supra-
molecular interactions between NS2 and cage A using Zp
measurements. We expected a shift of the initial negative Zp,
arising from three negatively charged sulfonate groups in pyr,
toward less negative or even positive values upon interaction
with cage A. When an aqueous solution of cage A (0.3 μM, 2
equiv with respect to the concentration of pyranine groups)
was added to an aqueous dispersion of NS2 (2 × 1011
particles/mL) Zp was found to shift from −37 ± 2 to +8 ±
2 mV, while further additions resulted in a further Zp shift up
to +32 mV (Figure 2B). Importantly, absorbance spectra and
TEM images confirmed that NS2 particles remained colloidally
stable after completion of host−guest complexation (Figure
2C,D).
Two types of PC are commonly distinguished, which are
known as “hard corona” and “soft corona”. On the one hand,
the hard corona (HC) is formed by proteins with high affinity
for the NP and is located next to the NP surface.27,28 On the
other hand, the soft corona includes proteins with lower
affinity, which get exchanged over time, and can be readily
detached upon repeated washing. Importantly, because the HC
remains adsorbed onto the NPs during biophysical events, it
exerts a significant influence over the NP physiological
properties.29 Therefore, we aimed at evaluating the effect of
cage A on the formation and stability of a HC on NS2.
We prepared four dispersions of NS2 in 200 μL of diluted
fetal bovine serum [FBS, 5% in phosphate-buffered saline
(PBS)], containing different amounts of cage A (0, 5, 10, and
20 μM), which was added before FBS. Dynamic light
scattering measurements confirmed the colloidal stability of
NS2 in the presence of 5% FBS (Figure S3). After incubation
for 30 min at room temperature, the nanoparticles were
separated from nonadsorbed proteins by centrifugation and
then extensively washed to remove all unbound proteins, until
the supernatant was free of any detectable protein as indicated
by the Bradford assay.30 Subsequently, the remaining adsorbed
proteins forming the HC were detached from NS2 by a
standard treatment with sodium dodecyl sulfate (SDS) (10%)
and dithiothreitol (DTT; 0.5 mM) at 90 °C for 10 min.31 The
protein content was analyzed by SDS polyacrylamide gel
electrophoresis (PAGE), which showed that as little as 5 μM of
cage is enough to reduce by more than half the amount of
adsorbed HC proteins, whereas using 20 μM of A led to a
fivefold reduction (Figure S4).
To confirm that the above effect is due to interactions
between cage A and pyr on NS2, we performed control
experiments using NPs lacking the pyranine moieties. We
synthesized AuNPs coated with a thiolated poly(ethylene
glycol) (NS-PEG) featuring a terminal methyl ether (HS-
PEG5000-O−CH3, Figure S6). HC formation around these
NPs was evaluated, both in the absence and in the presence of
10 μM A, using the above procedure. As expected, no
significant differences in the amount of adsorbed protein were
observed between both samples (Figure S4), thus excluding
the possibility that a direct interaction between cage A and
FBS proteins is the reason behind PC reduction. To rule out
the possibility of a direct interaction between cage A and the
NP surface, which might be hindered by the PEG polymer in
the case of NS2, we studied another NP type, NS-Lac, with a
short coating ligand bound to the NP surface. As expected, no
difference was observed in the amount of PC detected upon
addition of cage A or in its absence (Figure S7) To further
confirm that the effect of cage A is mediated by interactions
with pyranine, we used the intrinsic fluorescence of this
chromophore, which is partially quenched upon formation of
the host−guest complex.23 We observed that addition of
increasing concentrations of cage A to a colloidal dispersion of
NS2 in the presence of FBS (5% in PBS) does quench the
fluorescence emission of pyranines, again evidencing host−
guest complex formation, even in the presence of the proteins
present in FBS (Figure S8).
While the above experiments demonstrate that the presence
of cage A in the buffer affects the formation of a HC, the
question arises whether addition of this macromolecule to NPs
that are covered by a preformed HC can also disrupt the
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corona. We anticipated this goal to be challenging, since the
HC is assumed to be tightly bound to the NPs surface. We
additionally wondered whether the effect of cage A could be
reversed by adding free pyr (8-hydroxypyrene-1,3,6-trisulfonic
acid), which should compete for cage A and hence might
restore the initial PC composition on the NPs.
Therefore, we incubated NS2 with diluted FBS (5% in PBS)
for 30 min at 25 °C (total volume = 0.6 mL). We then
separated a 0.4 mL aliquot of this dispersion and added cage A
(20 μM), and the resulting mixture was kept at 25 °C for 10
min. Finally, to the 0.2 mL of the resulting dispersion, we
added 50 μM pyranine, and the mixture was incubated at 25
°C for 10 min. After nonadsorbed proteins were removed, we
applied the above-described protocol for HC release to the
three resulting 0.2 mL solutions, followed by both SDS-PAGE
analysis (Figure S5) and the bicinchoninic acid (BCA) assay
(Figure 3A). The results revealed that addition of cage A (20
μM) to NS2 featuring a preformed PC resulted in removal of
ca. 75%−79% of the HC after 10 min of incubation. This value
is similar to that obtained in the experiment where the cage
was added prior to FBS (82%). This result indicates that most
of the proteins forming the HC are not irreversibly adsorbed to
the surface of NS2, as they can be released under
biocompatible conditions upon addition of the positively
charged cage A. The BCA assay was also performed to quantify
the protein recovered in the washing steps. Such experiments
showed that, in the absence of cage A, only ca. 50% of the
initial proteins used in the incubation were recovered in the
Figure 3. Comparison of the amount and type of FBS proteins immobilized on NS2 particles upon addition of cage A and pyr. (A) (top)
Schematic representation of the NP-protein system for each gel line. (bottom) NS2: BCA analysis for only NS2 (200 μL, 7.5 × 1011
particles/mL) diluted in FBS (5% in PBS). NS2 + A: same conditions as NS2 lane, followed by addition of 20 μM of cage A and 10 min of
incubation. NS2 + A + pyr: same conditions as NS2 + A, followed by addition of 50 μM of free pyr and 10 min of incubation. (B) Cyclic
addition to a colloidal dispersion of NS2 (1.5 mL, 7.5 × 1011 particles/mL) in diluted FBS (5% in PBS), with 10 μM of cage A (blue arrow)
and 30 μM of free pyr (red arrow). After each addition, the dispersion was incubated for 10 min. Subsequently, the amount of adsorbed
protein on 1.5 × 1011 particles was evaluated by stacking SDS-PAGE (bottom) and quantified using ImageJ (top). (C) List of proteins
comprising the PC on NS2, for which the relative abundance increases or decreases more than threefold during the cage/pyranine cycle of
the former SDS-PAGE assay, based on LC-MS/MS analysis. The ratio parameter is defined as the average relative abundance of the protein
in steps 2, 4, and 6, (low protein immobilization) divided by the relative abundance in steps 1, 3, and 5 (high protein immobilization). Steps
1−6 are normalized to the abundance of the protein in each step.
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washing steps, whereas in the presence of A the recovery
increased up to 86% (Figure S9).
The former assay also demonstrated that addition of pyr
facilitates the recovery of the initial HC, likely because cage A
is removed from the NP surface (Figure 3A). Moreover,
reversible control of PC formation over NS2 could be
repeatedly performed by successive additions of cage A and
free pyr, thereby confirming the reversible character of this
adsorption switching process (Figure 3B) and the possibility of
regulating PC formation on AuNPs through external additives.
For completeness, NS2 was also incubated with 100% rat
serum for 10 min. Subsequently, 100 μM of cage A was added,
and the BCA assay was again performed to compare the
amount of protein remaining on NS2, before and after cage
addition. A decrease of 30% in protein adsorption was
observed after cage addition, thereby proving that the
supramolecular strategy can even be applied under in vivo-
like, complex biological conditions (Figure S10).
As a control experiment to evaluate whether other positively
charged polyamine molecules can be used instead of cage A,
NS2 was incubated with 20 μM of spermine, in the presence of
diluted FBS (5% in PBS). The BCA assay showed a reduction
of 20% in the amount of protein adsorption, which is far less
efficient than the 80% reduction observed for cage A under the
same conditions (Figure S11). This result highlights the
importance of a high affinity between both oppositely charged
molecules, to obtain an efficient disruption of the PC.
Further insights regarding the effect of supramolecular
interactions between A and NS2 on PC composition were
obtained through a comprehensive comparison between
electrospray liquid chromatography mass spectrometry (LC-
MS/MS) profiles of protein coronas formed on NS2 dispersed
in 5% FBS, before and after addition of 10 μM cage A. This
assay showed significant differences in the relative abundance
of several proteins after addition of cage A (see Table S1, steps
1 and 2), thereby proving that not all proteins are equally
affected by host−guest complex formation. Furthermore, to
evaluate whether the PC composition can also be reversibly
controlled, five steps of cage A and pyr additions were
performed with NS2, and an LC-MS/MS assay was performed
for each step (Figure 3C and Tables S1 and S2). These results
showed similar levels of relative abundance for each protein in
the steps with high protein adsorption (steps 1, 3, and 5).
Accordingly, the steps with low protein adsorption also gave
similar values (steps 2, 4, and 6), thereby confirming the ability
of our approach to reversibly regulate the composition and the
amount of proteins of the HC on NPs.
A detailed analysis of PC composition in all steps allowed us
to identify as many as 26 different proteins whose abundance
after addition of cage A was reduced or increased by at least
twofold (see Table S1) and 10 of them with a reduction by
one-third (Figure 3C). The protein with the greatest reduction
was β-enolase, which presents an overall reduction of 85% in
the steps with low protein adsorption. The biological function
of this protein is related to the development and regeneration
of muscles. The only protein with more than twice increased
presence after addition of cage A was the Tudor domain-
containing protein 7, which is a component of specific
cytoplasmic RNA granules involved in post-transcriptional
regulation of several genes.
In an attempt to understand the variation in PC
composition, we compared the isoelectric points, molecular
weights, and aliphatic indexes of the different proteins. No
correlation was observed between these parameters and
variations in relative abundance. For instance, comparing the
10 proteins showing the most significant variations after cage A
addition (Figure 3C), we found molecular weights between 50
and 500 kDa, isoelectric points between 5.3 and 8.7, and
aliphatic indexes between 90 and 54. However, we also found
that 8 of 26 proteins with the highest variation were involved
in negative regulation of endopeptidase activity and 6 in blood
coagulation. This unexpected specificity likely emerges from a
structural similarity between local regions of proteins
exhibiting similar biological roles32 and further proves the
biological potential of our host−guest recognition strategy as a
tool to control PC composition.
The above results confirmed that, via the use of host−guest
interactions between cage A and exposed pyr, it is possible to
disrupt protein adsorption on the NPs surface and that, by the
addition of defined amounts of cage A and pyr, we can achieve
efficient and reversible regulation on PC formation. While the
precise molecular mechanism behind PC disruption is not
entirely clear, it might be related to the presence of zwitterionic
surface ligands, that is, ligands carrying both positive and
Figure 4. Uptake experiments in HeLa cells. (A) All NPs were incubated with cells using DMEM medium supplemented with 10% FBS, for
24 h, at 9 × 1010 NP/mL. For NS2 + cage A, 5 μM cage A was used. Zp values for each NP are indicated below the graph. The degree of
internalization was quantified by ICP-MS. (B) TEM images of a HeLa cell incubated under the conditions described for NS2 + A.
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negative charges, which favor the formation of a tight
hydration layer around the NPs.33 Indeed, although the
supramolecular nanocomposite formed by pyranine containing
NS2 and cage A presents a similar Zp (+32 mV) as NS1 (+29
mV, one amino group per PEG ligand), 10 times more
proteins were found to adsorb on NS1 than on the mixture of
NS2 and 10 μM of A (Figures S12 and S4).
As mentioned in the introduction, PC formation hinders the
contact between AuNPs and mammalian cell membranes,
thereby preventing efficient internalization.34,35 We anticipated
that our supramolecular approach might promote cellular
uptake and eventually implement a stimuli-responsive control
on the internalization. We performed 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) cell viability
assays to assess the toxicity of NS2, both in the absence and
in the presence of cage A, using human HeLa cells in
Dulbecco’s Modified Eagle’s Medium (DMEM) medium
containing 10% FBS. No cytotoxicity was observed for NS2
at concentrations up to 9 × 1010 particles/mL after 24 h of
incubation (Figure S13). A slight decrease in cell viability
(∼10%) was observed when incubation was performed in the
presence of 5 μM cage A. This toxicity increase might be
attributed to a superior NP uptake under these conditions
(vide inf ra). Considering the low-to-absent levels of AuNP-
induced cytotoxicity, we used the selected concentration (9 ×
1010 particles/mL) for all subsequent experiments with HeLa
cells.
Cell uptake of NS2 by HeLa cells, in the absence and
presence of cage A, was studied using inductively coupled
plasma-mass spectrometry (ICP-MS) to quantify the amount
of internalized AuNPs. Incubation of HeLa cells with NS2 for
24 h, using DMEM with 10% FBS and appropriate washings,
resulted in the internalization of 5800 ± 2000 particles/cell.
When the same experiment was repeated in the presence of 5
μM cage A, cellular uptake increased by over an order of
magnitude (74 000 ± 4000 particles/cell, Figure 4A). By using
a larger amount of cage A (10 μM), we found a further
increase in cellular uptake (up to 96 000 ± 2000 particles/cell,
17-fold with respect to the experiment without cage A).
Additionally, in agreement with SDS-PAGE PC studies, when
incubation was performed using 5 μM cage A and 10 μM free
pyr, cellular uptake decreased by half (35 000 ± 10 000
particles/cell), as compared to the same experiment in the
absence of pyr. Bio-TEM images of HeLa cells exposed to NS2
and cage A confirmed intracellular localization of AuNPs
(Figure 4B), showing a large number of NPs clustered in
cellular vesicles, as expected for an endosomal internalization
pathway. In agreement with ICP-MS results, when the same
incubation was performed in the absence of cage A, almost no
NPs were found inside cells in TEM images (Figure S14).
One of the main limitations that hamper the application of
NPs in medicine is the low delivery efficiency. For example, the
delivery efficiency of purpose-designed NPs for solid tumors is
usually less than 1% of the injected dose. The sequestration of
NPs by macrophages of the mononuclear phagocytic system is
one the main reasons behind this problem.10 To evaluate the
generality of HC modulation as a means to regulate NP
internalization, and the possibility of this strategy to avoid the
mononuclear phagocytic system, cell uptake experiments were
also performed using a phagocytic macrophage-like cell line
(J774). It has been reported that the PC has a lower impact on
the overall internalization efficiency for macrophage cell
lines.36 Incubation of J774 cells with NS2 (3 × 1010
particles/mL), under the conditions described for HeLa cells,
induced a relatively low internalization (4977 ± 1000
particles/cell). When the experiment was repeated in the
presence of 5 μM cage A, NP uptake increased by 1 order of
magnitude (50 000 ± 6000 particles/cell). These results
confirm that the supramolecular strategy can be used to
enhance cell internalization of relatively large NPs into various
cell types, including those from the mononuclear phagocyte
system, but they also indicate that the approach might
eventually be used to hide NPs from the mononuclear
phagocyte system.
In our previous work,26 we applied the cage/pyranine
complex to trigger cellular internalization of 2 nm AuNPs,
which have low nonspecific protein adsorption due to their
small size,37 and concluded that the uptake switch of small NPs
was related to the change in surface charge from negative to
positive. We thus explored whether the switch in cell uptake
for larger NS2 (15 nm) was associated with HC disruption,
rather than to a mere inversion in surface charge. We therefore
performed control uptake experiments with HeLa cells, using
NS-PEG and amino-terminated NS1, in the presence of FBS.
NS-PEG features neutral AuNP surfaces (Zp −3 mV), whereas
NS1 particles are positively charged (Zp +29 mV), similar to
NS2 in the presence of cage A (Zp +32 mV). Note that the
size of the PC in these NPs was similar to that of NS2 in the
absence of cage (Figures S4 and S12). Upon incubation, we
determined internalization of 600 ± 400 particles/cell for NS-
PEG and 2000 ± 1000 particles/cell for NS1, that is, a much
lower uptake efficiency than for NS2 in the presence of cage A
(74 000 ± 4000 particles/cell, Figure 4A). In agreement with
the HC disruption mechanism, when the incubation of cells
was performed in the absence of FBS, that is, without the PC
effect, the uptake of NS2 in the presence of cage was only 3
times higher than that of NS1, 210 000 ± 40 000 and 74 000 ±
10 000 particles/cell, respectively. Taking into consideration
these results and the poor cell internalization ability of cage
A,25 we can safely conclude that the internalization of NS2
promoted by a supramolecular mechanism is related to the
disruption of the HC. However, it has been shown that, in
some cases, zwitterionic NPs display a lower cellular uptake
than cationic NPs, even in the presence of FBS.38 Therefore,
we propose that the dramatic increase in cellular uptake
observed in our system stems from a synergistic effect between
PC suppression and the charge switch from negative to
positive.
Finally, considering that AuNPs induce local heating when
illuminated by a resonant laser,39 we explored the application
of the conditional cell uptake strategy to enhance photo-
thermal therapy. Gold nanorods (AuNRs) are particularly
interesting for hyperthermia applications, because their
longitudinal localized surface plasmon resonance (LSPR) can
be readily tuned within the near-infrared (NIR) region (700−
850 nm), that is, within the first biological transparency
window.40 Although AuNRs can efficiently absorb and scatter
light, absorption largely dominates for small NRs,41 which is
highly beneficial for efficient plasmonics-based photothermal
therapy. In this context, we investigated the application of our
conditional uptake strategy with small AuNRs (29 × 9 nm)
featuring a longitudinal LSPR centered around 800 nm (Figure
5a). AuNRs (NR1) were synthesized by seeded growth,42 and
their surface was subsequently decorated with pyranines,
following the same protocol used for NS2, thus resulting in an
equivalent NR3 (Figure S15).
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As expected from our results with nanospheres, when cage A
(5 μM) was mixed with NR3 in dilute FBS (5%), the amount
of adsorbed proteins in the HC was reduced by more than half
with respect to the system without cage (Figure S16). The
cellular uptake behavior of NR3 was similar to that of NS2;
that is, when a dispersion of 9 × 1010 NR/mL was added to
HeLa cells and the mixture was incubated for 24 h using
DMEM with 10% FBS, we determined a cellular uptake of only
4000 ± 1000 NR/cell, which increased to 126 000 ± 20 000
particles/cell (30-fold increase) in the presence of 5 μM cage A
(Figure 5B).
We then explored whether the cage-responsive uptake of
NR3 could be used for conditional control of cytotoxicity, in
combination with NIR irradiation. HeLa cells were incubated
with NR3 in DMEM with 10% FBS for 24 h, both in the
absence and in the presence of cage A. Control experiments
showed that NR3 is not cytotoxic at this concentration,
regardless of the presence of cage A (Figure 5D, blue bars).
After incubation, cells were washed twice with PBS to remove
noninternalized AuNRs and then irradiated using a fiber-
coupled 808 nm diode laser for 20 min. The viability of cells
treated with NR3 only was roughly the same as that of non-
irradiated cells. However, for those cells incubated with NR3 in
the presence of cage A, the viability was reduced to 34% due to
heat released from NR3 during laser irradiation (Figure 5D).
CONCLUSIONS
We have presented an efficient strategy for stimuli-responsive,
reversible control of protein corona formation over gold
nanoparticles. The approach is based on the supramolecular
interaction between surface-exposed pyranines and positively
charged supramolecular cages, resulting in the generation of
PC-disrupting zwitterionic ligands. The strategy is fully
reversible, so that the PC status can be fully controlled by
varying amounts of cage A and externally added pyranines.
Cellular uptake experiments with both cancer and phagocytic
cells confirmed that this stimuli-responsive PC regulation
provides an accurate handle over cell internalization of AuNPs,
which is enhanced in the presence of the external cage. It was
observed that PC composition after addition of the cage was
preferentially impoverished in specific serum proteins with
comparable functions. Therefore, this conditional release of
specific proteins, which can be reversibly controlled by the
addition of cage A and pyr, might find interesting biological
applications. Finally, preliminary optical hyperthermia studies
demonstrate the feasibility of regulating the laser-induced
cytotoxicity of Au nanorods using external additives. This dual
control on the toxicity using light and organic molecules is
promising and deserves further studies, owing to its biomedical
potential.
METHODS
Synthesis of NS1. Citrate-stabilized Au nanospheres (Au NSs) of
14.8 nm of diameter were synthesized according to the standard
Turkevich method.43 An aqueous suspension of as-synthesized citrate-
stabilized Au NSs (0.4 mM in Au, 2 mL) was placed in a 2 mL
centrifuge tube (1 mL solution in each tube). Then, a solution 10 mM
of α-amino-ω-mercapto poly(ethylene glycol) hydrochloride (HS-
PEG-NH2) (MW = 5000, 68 μL, calculated to provide 200 molecules
per nm2) was added under stirring to each tube and incubated at
room temperature for 1 h. Subsequently, AuNPs were centrifuged
(18 500g, 30 min) and washed with water three times. Finally, the
tubes were centrifuged again to increase the concentration, and the
concentrated dispersions from both tubes were mixed.
Synthesis of NS2. Pyr-CO2H was covalently conjugated to NS1
with the aid of 1-ethyl-3-(3 dimethylaminopropyl)carbodiimide
(EDC) and N-hydroxysuccinimide (NHS). Pyr-CO2H (7.0 mg,
0.012 mmol), EDC (3.4 mg, 0.018 mmol), and NHS (2.0 mg, 0.018
mmol) were dissolved in 0.6 mL of 2-ethanesulfonic acid (MES)
buffer (0.1 M, pH = 6.4). The mixture was stirred for 15 min at room
temperature to activate the dye. This solution was subsequently added
to a 200 μL solution of NS1 ([Au] = 1.44 mM) and stirred at room
temperature for 14 h. The AuNSs were then centrifuged (18 500g, 30
min) and washed several times with phosphate buffer (20 mM, pH
7.5) and Milli-Q water, until no Pyr-CO2H was detected in the
washing phase. Finally, the nanoparticles were dispersed in 500 μL of
Milli-Q water.
Synthesis of NR1. NR1 (longitudinal LSPR at 800 nm; length 29
nm; width 9 nm) was prepared using the seeded-growth method with
some modifications, as previously described by Nikoobakht and El-
Sayed.44 Seeds were prepared by the standard cetyl trimethylammo-
nium bromide (CTAB)/NaBH4 procedure: 25 μL of a 0.05 M
HAuCl4 solution was added to 4.7 mL of a 0.1 M CTAB solution,
followed by injection of 300 μL of a freshly prepared 0.01 M NaBH4
solution, under vigorous stirring (1500 rpm). Excess borohydride was
consumed by aging the seed solution for 30 min at room temperature
Figure 5. (A) UV−Vis−NIR spectrum of NR3. (B) Cell uptake of
NR3 (9 × 1010 NR/mL) by HeLa cells, in the absence and in the
presence of cage A (5 μM), as determined by ICP-MS. The
incubation was performed in DMEM medium with 10% FBS for 24
h. (C) Schematic representation of the protocol followed in the
NIR-laser hyperthermia experiments. HeLa cells were first
incubated with NR3 (9 × 1010 NR/mL) for 24 h in DMEM
medium with 10% FBS, with or without 5 μM cage A.
Subsequently, noninternalized nanorods were removed by washing
with PBS, and cells were irradiated with an 808 nm diode laser
(Lumics, LU808T040) for 20 min at a power density of 3.2 W/
cm2. Cell viability was calculated using the MTT assay (average of
triplicate wells ± standard deviation). (D) Results of the
irradiation experiment. The control bar (black) represents cell
viability of the cells in the absence of cage A and NR3. Blue bars
represent incubation without irradiation, proving that uptaken
NR3 in the presence of cage A did not induce cytotoxicity.
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prior to use. In a typical synthesis of a 50 mL Au NR solution, 500 μL
of 0.01 M AgNO3, 1 mL of 1 M HCl, 500 μL of a 0.05 M HAuCl4,
and 800 μL of 0.1 M ascorbic acid solution were added to 50 mL of
0.1 M CTAB. Then, 3 mL of the seed solution was added under
stirring. The mixture was left undisturbed at 25 °C for at least 6 h.
The resulting gold nanorods were centrifuged in 50 mL tubes (5000g,
60 min) to remove spherical impurities. The precipitate was
discarded, and the supernatant was centrifuged at 18 500g for 45−
60 min in 2 mL tubes. The precipitate was redispersed in 4 mL of a 2
mM CTAB solution. The concentrated Au NR colloid was
centrifuged again at 18 500g for 45−60 min. This step was repeated
twice.
Synthesis of NR2. An aqueous dispersion of NR1 (0.4 mM in Au,
1 mM of CTAB, 10 mL) was placed in 2 mL centrifuge tubes (1 mL
solution in each tube). The dispersions were centrifuged (18 500g, 30
min) to reduce the volume to 100 μL. At this point, a 10 mM solution
of HS-PEG-NH2 (MW = 5000, 71 μL, calculated to provide 200
molecules per nm2) was added under stirring to each tube.
Subsequently, 800 μL of water was added, and the vials were stirred
for 3 h. Finally, the AuNPs were centrifuged (18 500g, 30 min) and
washed with water three times. Finally, the tubes were centrifuged
again to increase the concentration, and the concentrated dispersions
from both tubes were mixed.
Synthesis of NR3. Pyr-CO2H was covalently conjugated to NR2
with the aid of EDC and NHS. Pyr-CO2H (7.0 mg, 0.012 mmol),
EDC (3.4 mg, 0.018 mmol), and NHS (2.0 mg, 0.018 mmol) were
dissolved in 0.6 mL of MES buffer (0.1 M, pH = 6.4). The mixture
was stirred for 15 min at room temperature to activate the dye. This
solution was subsequently added to a 200 μL solution of NR2 ([Au]
= 1.40 mM) and stirred at room temperature for 14 h. Finally, Au
NRs were centrifuged (18 500g, 30 min) and washed several times
with phosphate buffer (20 mM, pH 7.5) and Milli-Q water, until no
Pyr-CO2H was detected in the washing phase. Finally, the NRs were
dispersed in 500 μL of Milli-Q water.
Quantification of Pyranine in NS2. The amount of pyranine
dye bound to NS2 was determined by ICP-MS, for the determination
of the amount of gold. The average diameter was estimated from
TEM micrographs of NS2 (14.8 ± 0.9 nm), and the number of gold
atoms per NS was deduced according to the density of gold (1.932 ×
10−20 g/nm3). The amount of pyr in solution was calculated using
fluorescence spectroscopy after etching of NS2 with KCN (380 nm
excitation wavelength). The fluorescence signal obtained at 430 nm
after etching was used to calculate the amount of pyr in solution,
using a calibration curve for Pyr-CO2H. The number of pyr molecules
per NS was ca. 408.
Proteins Immobilized on NPs in the Presence and Absence
of Cage A. To study the protein corona on gold nanoparticles, a
dispersion of the corresponding NPs (7.5 × 1011 particle/mL) was
prepared using diluted FBS [5% in 10 mM PBS] or 100% rat serum
following the conditions described in the main text. Once the
incubation was performed, AuNPs (1.5 × 1011) were separated from
nonadsorbed proteins by careful centrifugation (10 °C, 19 000g, 30
min). In those cases in which the incubation was performed in the
presence of cage A (with the exception of those incubations in which
free pyr was subsequently added), the next washing step was
performed using an aqueous solution of cage A (5 μM) to avoid the
interaction between remaining FBS proteins and the NPs, after
removal of A in the first washing step. Subsequently, AuNPs were
extensively washed with PBS by centrifugation at 19 000g and 10 °C
for 10 min, to remove all unbound proteins, until the supernatant was
free of any detectable protein by Bradford assay. Absorbance values at
400 nm confirmed in all cases the quantitative recovery of the NPs
during the washing steps. Subsequently, the remaining adsorbed
proteins, forming the HC, were detached from AuNPs upon
treatment with SDS (10%) and DTT (0.5 mM) at 90 °C for 10
min. The protein content was analyzed by SDS-PAGE or the BCA
assay (see Supporting Information), and the chemical composition of
HC was analyzed by LC-MS/MS.
SDS-PAGE Electrophoresis. Proteins immobilized on AuNPs
(1.5 × 1011 particles) were mixed with 20 μL of Novex Tris-Glycine
SDS buffer (1X Thermo Scientific), 5 μL of NuPAGE reducing buffer
(10x, Thermo Scientific), and 10 μL of Milli-Q water. The mixture
was boiled for 2 min at 95 °C. Treated samples were then loaded in
Novex Tris-Glycine MiniGel of 10 wells 4−20% (Thermo Scientific),
and the gels were run for 45 min at 120 mV in Novex Tris-Glycine
SDS (1X) running buffer. Staining was performed with Coomassie
Blue (Aldrich) for 2 h, followed by washing in Milli-Q water for 3−4
d. Proteins adsorbed onto AuNPs were quantified by using ImageJ.
Mass Spectrometry. Proteins immobilized onto AuNPs (1.5 ×
1011 particles) were mixed with 20 μL of Novex Tris-Glycine SDS
buffer (1X Thermo Scientific), 5 μL of NuPAGE reducing buffer
(10X, Thermo Scientific), and 10 μL of Milli-Q water. The mixtures
were boiled for 2 min at 95 °C. Treated samples were then loaded in
Novex Tris-Glycine MiniGel of 10 wells 10% (Thermo Scientific),
and the gels were run for 5 min at 120 mV in Novex Tris-Glycine SDS
(1X) running buffer. Staining was performed with Coomassie Blue
(Aldrich) for 2 h, followed by washing in Milli-Q water for 3−4 d.
Proteins adsorbed onto AuNPs were quantified by using ImageJ.
Bands of interest were washed in milli-Q water. Reduction and
alkylation were performed using ditiothreitol (10 mM DTT in 50 mM
ammonium bicarbonate) at 56 °C for 20 min, followed by
iodoacetamide (50 mM iodoacetamide in 50 mM ammonium
bicarbonate) for another 20 min in the dark. Gel pieces were dried
and incubated with trypsin (12.5 μg/mL in 50 mM ammonium
bicarbonate) for 20 min on ice. After rehydration, the trypsin
supernatant was discarded; gel pieces were hydrated with 50 mM
ammonium bicarbonate and incubated overnight at 37 °C. After
digestion, acidic peptides were cleaned with trifluoroacetic acid
(TFA) 0.1% and dried out in a RVC2 25 speedvac concentrator
(Christ). Peptides were resuspended in 10 μL 0.1% formic acid (FA),
sonicated for 5 min, and analyzed by LC-MS/MS. For a complete
description on LC/MS/MS see Supporting Information.
Cell Cultures and Internalization Studies. HeLa or J774 cells
were plated in 96-well microplates, 1.4 × 104 cells/well, and allowed
to adhere overnight. The following day cell media was replaced with
nanoparticle solution (final concentration 9 × 1010 particles/mL for
HeLa cells and 3 × 1010 particles/mL for J774 cells) diluted in
DMEM/FBS (two wells for each replicate). Cells were incubated with
NPs for 24 h at 37 °C, followed by removal of the NPs and two
washing steps with DMEM/FBS. Adherent cells were trypsinized, and
samples were frozen overnight at −20 °C (at this point, the duplicate
wells were combined). The resulting cell lysates were digested for 48
h using 500 μL of aqua regia. The sample solutions were then diluted
to 3 mL with deionized water. The assays were performed in triplicate
for each particle. The cells were counted prior to the addition of aqua
regia to determine the number of cells.
The gold concentration in colloidal samples was determined by
ICP-MS under the following operating conditions: Radio frequency
power: 1550 W; plasma Ar flow rate: 14 L/min; nebulizer Ar flow
rate: 1.12 L/min; auxiliary gas rate: 0.8 L/min; isotopes were
monitored in kinetic energy determination (KED) mode: 197Au/
193Ir (internal standard); dwell time: 10 ms; quartz cyclonic spray
chamber.
Cellular Uptake Imaging by TEM. TEM was used to study the
intracellular location of NP2, with and without cage A. HeLa cells
were plated at 2 × 105 cells/well in a 12-well plate. Cells were allowed
to adhere overnight, followed by addition of NP2 (9 × 1010 NP/mL),
with and without cage A (5 μM). After 24 h of incubation, cells were
washed and trypsinized. Cell pellets were washed with Sorensen’s
buffer (0.1 M) and fixed with a 2% formaldehyde/2.5%
glutaraldehyde solution in Sorensen’s buffer, initially for 10 min at
room temperature, followed by replacement of the fixing solution and
incubation at 4 °C for 4 h. Samples were washed with Sorensen’s
buffer, stained with 1% OsO4, dehydrated, and embedded in Spurr’s
resin. Once polymerized, 60 nm thick slices were cut using an
ultramicrotome. Samples were imaged using TEM (JEOL JEM-
1400PLUS, 40−120 kV).
NR3 Irradiation Assays. HeLa cells were plated in a 96-well plate
at 1.4 × 104 cells/well and allowed to adhere overnight. The following
day media was replaced with NR3, in the presence or absence of cage
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A. NRs were left overnight with cells (∼24 h) followed by laser
irradiation after removing nonendocytosed NPs. Irradiation was
performed with an 808 nm diode laser, illuminating the whole well
(0.4 cm spot size) (t = 20 min, p = 3.2 W/cm2, VT = 200 μL/well).
Cell viability was analyzed using the MTT assay, and absorbance was
measured at 550 nm, showing both non-irradiated and irradiated
wells, and in presence or absence of cage A.
ASSOCIATED CONTENT
*sı Supporting Information
The Supporting Information is available free of charge at
https://pubs.acs.org/doi/10.1021/acsnano.9b08752.
General experimental procedures, nanoparticles charac-
terization, protein corona studies, mass spectrometry
analysis, cell viability assays (PDF)
AUTHOR INFORMATION
Corresponding Authors
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Ikerbasque, Basque Foundation for Science, 48013 Bilbao,
Spain; orcid.org/0000-0002-6647-1353;
Email: llizmarzan@cicbiomagune.es
Authors
Isabel García − CIBER de Bioingenieriá, Biomateriales y
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Materiais Moleculares (CIQUS), Universidade de Santiago de
Compostela, 15782 Santiago de Compostela, Spain;
orcid.org/0000-0001-7059-0956
Mo ́nica Dhanjani − CIC biomaGUNE, Basque Research and
Technology Alliance (BRTA), 20014 Donostia-San Sebastiań,
Spain
Jose ́ L. Mascareñas − Departamento de Quiḿica Orgańica and
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authors thank G. Gonzaĺez-Rubio for providing NR1. This
work was performed under the Maria de Maeztu Units of
Excellence Program from the Spanish State Research Agency,
Grant No. MDM-2017-0720.
DEDICATION
Dedication Dedicated to Professor E.W. “Bert” Meijer on the
occasion of his 65th birthday.
REFERENCES
(1) Mura, S.; Nicolas, J.; Couvreur, P. Stimuli-Responsive Nano-
carriers for Drug Delivery. Nat. Mater. 2013, 12, 991−1003.
(2) Kim, D.; Shin, K.; Kwon, S. G.; Hyeon, T. Synthesis and
Biomedical Applications of Multifunctional Nanoparticles. Adv. Mater.
2018, 30, 1802309.
(3) Lee, D.-E.; Koo, H.; Sun, I.-C.; Ryu, J. H.; Kim, K.; Kwon, I. C.
Multifunctional Nanoparticles for Multimodal Imaging and Therag-
nosis. Chem. Soc. Rev. 2012, 41, 2656−2672.
(4) Pelaz, B.; Alexiou, C.; Alvarez-Puebla, R. A.; Alves, F.; Andrews,
A. M.; Ashraf, S.; Balogh, L. P.; Ballerini, L.; Bestetti, A.; Brendel, C.;
Bosi, S.; Carril, M.; Chan, W. C. W.; Chen, C.; Chen, X.; Chen, X.;
Cheng, Z.; Cui, D.; Du, J.; Dullin, C.; et al. Diverse Applications of
Nanomedicine. ACS Nano 2017, 11, 2313−2381.
(5) Huang, X.; El-Sayed, M. A. Gold Nanoparticles: Optical
Properties and Implementations in Cancer Diagnosis and Photo-
thermal Therapy. J. Adv. Res. 2010, 1, 13−28.
(6) Giljohann, D. A.; Seferos, D. S.; Daniel, W. L.; Massich, M. D.;
Patel, P. C.; Mirkin, C. A. Gold Nanoparticles for Biology and
Medicine. Angew. Chem., Int. Ed. 2010, 49, 3280−3294.
(7) Sperling, R. A.; Rivera Gil, P.; Zhang, F.; Zanella, M.; Parak, W.
J. Biological Applications of Gold Nanoparticles. Chem. Soc. Rev.
2008, 37, 1896−1908.
(8) Ayala-Orozco, C.; Urban, C.; Knight, M. W.; Urban, A. S.;
Neumann, O.; Bishnoi, S. W.; Mukherjee, S.; Goodman, A. M.;
Charron, H.; Mitchell, T.; Shea, M.; Roy, R.; Nanda, S.; Schiff, R.;
Halas, N. J.; Joshi, A. Au Nanomatryoshkas as Efficient Near-Infrared
Photothermal Transducers for Cancer Treatment: Benchmarking
against Nanoshells. ACS Nano 2014, 8, 6372−6381.
(9) Popovtzer, R.; Agrawal, A.; Kotov, N. A.; Popovtzer, A.; Balter,
J.; Carey, T. E.; Kopelman, R. Targeted Gold Nanoparticles Enable
Molecular CT Imaging of Cancer. Nano Lett. 2008, 8, 4593−4596.
(10) Wilhelm, S.; Tavares, A. J.; Dai, Q.; Ohta, S.; Audet, J.; Dvorak,
H. F.; Chan, W. C. W. Analysis of Nanoparticle Delivery to Tumours.
Nat. Rev. Mater. 2016, 1, 16014.
(11) Gustafson, H. H.; Holt-Casper, D.; Grainger, D. W.;
Ghandehari, H. Nanoparticle Uptake: The Phagocyte Problem.
Nano Today 2015, 10, 487−510.
(12) Nguyen, V. H.; Lee, B.-J. Protein Corona: A New Approach for
Nanomedicine Design. Int. J. Nanomed. 2017, 12, 3137−3151.
(13) Salvati, A.; Pitek, A. S.; Monopoli, M. P.; Prapainop, K.;
Bombelli, F. B.; Hristov, D. R.; Kelly, P. M.; Åberg, C.; Mahon, E.;
Dawson, K. A. Transferrin-Functionalized Nanoparticles Lose Their
Targeting Capabilities When a Biomolecule Corona Adsorbs on the
Surface. Nat. Nanotechnol. 2013, 8, 137−143.
ACS Nano www.acsnano.org Article
https://dx.doi.org/10.1021/acsnano.9b08752
ACS Nano 2020, 14, 5382−5391
5390
(14) Lesniak, A.; Salvati, A.; Santos-Martinez, M. J.; Radomski, M.
W.; Dawson, K. A.; Åberg, C. Nanoparticle Adhesion to the Cell
Membrane and Its Effect on Nanoparticle Uptake Efficiency. J. Am.
Chem. Soc. 2013, 135, 1438−1444.
(15) Mosquera, J.; García, I.; Liz-Marzań, L. M. Cellular Uptake of
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